Hou P , Shi J , White KM , Gao Y , Cui J .

R01 NS092570 National Institute of Neurological Disorders and Stroke, R01 HL126774 National Heart, Lung, and Blood Institute, AHA 18POST34030203 American Heart Association , R01 NS092570 NINDS NIH HHS , R01 HL126774 NHLBI NIH HHS , 18POST34030203 American Heart Association-American Stroke Association

	Figure 1. ML277 specifically changes the slow component of KCNQ1 currents.(A) KCNQ1 currents from Xenopus oocytes recorded before (black) and after (blue) adding 1 µM ML277. The test voltages were from −120 mV to 80 mV with 20 mV increments, and then returned to −40 mV for measuring the tail currents. (B) 1 µM ML277 effects on KCNQ1 +KCNE1 channels with injected mRNA weight ratio of KCNQ1:KCNE1 = 300:1 (left, unsaturated KCNE1 binding) and 4:1 (right, saturated KCNE1 binding). The test voltages were 40 mV for 4 s, and then returned to −40 mV. (C) Activation time constants (τ) of KCNQ1 currents recorded at +40 mV before (black) and after (blue) adding ML277. The time constants of the fast component (τf) and slow component (τs) were 48 ± 3 ms and 0.60 ± 0.03 s for control, and 52 ± 3 ms and 0.99 ± 0.07 s for after adding ML277. The p values were 0.37 for τf, and 0.00091 for τs, t-test, n ≥ 4. (D) Averaged results of activation time constants (τf and τs) of KCNQ1 currents recorded at different voltages before (black) and after (blue) adding ML277. n ≥ 4. (E) The increased current by ML277 (IML277-IControl, Δ current) from panel A. The first 1 s activation currents were shown with insets of enlarged scales, and different colors were utilized to show the ‘delay’ of the increased currents at different voltages. (F–G) KCNQ1 currents recorded before (black) and after (blue) adding ML277 with 5 s time duration at −50 mV (F) and 100 ms time duration at +40 mV (G). The tail currents were recorded at −60 mV. Voltage protocols are shown on the top. All error bars in this and other figures are ± SEM.
	Figure 2. ML277 right shifts the G–V relationship of KCNQ1 channels.(A) G–V relationships of KCNQ1 channels before (black) and after (blue) adding 1 µM ML277. Data points were fitted with a Boltzmann function. n = 25. (B) Normalized G–V relationships from panel A. (C) Averaged results of V50 of G–V relations (voltage at which the G–V is half maximal). The V50 for KCNQ1 channels is −26.8 ± 0.6 mV in control (black), and −20.3 ± 0.6 mV after adding ML277 (blue), with a significant difference (p=5×10−10, paired t test. n = 25). The V50 of IKs channels (KCNQ1 +KCNE1) (25.6 ± 3.1 mV, n = 4, red) is also for comparison. (D) G–V relationships of the KCNQ1 channels before (black) and after (blue) adding 1 µM ML277, and of IKs channels (red). IO/AO composition in each type of channels is indicated in parentheses.
	Figure 3. ML277 changes inactivation of KCNQ1 channels.(A) KCNQ1 tail currents recorded with pre-pulses of increasing time duration in 100 mM K+ solution. The pre-pulses were +60 mV with time durations ranging between 0.03 and 4.355 s, and the test pulse was −120 mV for 2 s. The inset shows the hook in tail currents with an expanded time scale. The current recorded with a 2.913 s pre-pulse duration is shown in red. (B) KCNQ1 tail current recorded with a 2.913 s pre-pulse duration (red) was fitted with a double exponential function F(t) = A1×exp(−t/τ1)+ A2×exp(−t/τ2)+C (Hou et al., 2017). The fitting curve is shown in dotted green line, the deactivation component (A1 ×exp(−t/τ1)+C) and hook component (A2 ×exp(−t/τ2)) are shown in green lines. (C) KCNQ1 tail currents after applying ML277 recorded with pre-pulses of increasing time durations in 100 mM K+ solution, with the same voltage protocol shown as in panel A. The inset shows the hook in tail currents with an expanded time scale. The current recorded with a 2.913 s pre-pulse duration is shown in red. (D) Normalized A2 of KCNQ1 hook currents before (black) and after (blue) adding ML277 vs. time durations of the pre-pulse (n ≥ 4). Data are fitted with a single exponential function.
	Figure 4. ML277 changes ion permeation of KCNQ1 channels.(A) Currents from KCNQ1 channels before (left) and after (middle) adding 1 µM ML277, as well as IKs channels (KCNQ1 +KCNE1) (right) recorded in 100 mM K+ (black) or 100 mM Rb+ (gray) external solutions. The tail currents were elicited at −60 mV for 3 s from a pre-pulse of +60 mV for 5 s (top of left). (B) Averaged Rb+/K+ permeability ratios of tail current amplitudes for KCNQ1 before (3.1 ± 0.2, black) and after (1.1 ± 0.3) adding ML277, and for IKs channels (0.6 ± 0.1, red). All n ≥ 4.
	Figure 5. ML277 specifically increases the currents of mutant KCNQ1 channels that open only to the AO state.(A–B) 1 µM ML277 effects on E1R/R2E, E1R/R4E, S338F, and F351A mutant KCNQ1 channels. Currents were elicited at +40 mV for 4 s and then returned to −40 mV to record the tail currents. (C) Averaged percentage of ML277 induced current increase on E1R/R2E (14.2 ± 4.2%), E1R/R4E (95.5 ± 8.5%), S338F (0.14 ± 3.1%), and F351A (52.5 ± 6.3%). n ≥ 4.
	Figure 6. ML277 enhances currents of KCNQ1 channels but does not change VSD activation.(A) Fluorescence signals showing voltage sensor activation of pseudo-WT KCNQ1 channel (KCNQ1-C214A/G219C/C331A) before (black) and after (blue) adding 1 µM ML277. The signals after applying ML277 were normalized to the peak from the control to correct the effects of photobleaching. Scale bars are for the fluorescence signals before ML277 application. Inset shows current traces of pseudo-WT KCNQ1 channel before (black) and after (blue) adding ML277 at +40 mV. Right panels show VCF results of pseudo-WT KCNQ1 channel before (black) and after (blue) adding ML277 recorded at −60 mV, 0 mV, and 60 mV. (B) Fluorescence-voltage (F–V, n = 4) and G–V (n = 3) relationships of pseudo-WT KCNQ1 before (black) and after (blue) adding ML277. (C) A cartoon scheme to illustrate that ML277 specifically enhances E-M coupling when the VSD is at the activated state.
	Figure 7. Model simulations of ML277 effects on KCNQ1 channels.(A) Model simulations of KCNQ1 activation currents before (black) and after (blue) adding ML277. (B) Five-state Markov model to show the two open states gating processes of KCNQ1 channel. α and β are voltage-dependent transitions. k1-4 are E-M coupling rates (constant). Reducing the k2 by half (k2 = 853.08 for control, and k2 = 426.54 for adding ML277) can mimic the ML277 effects on KCNQ1 channel. To balance the model, β3 is also reduced by half for adding ML277 (see Materials and methods). (C–D) G–V relationships of simulated KCNQ1 before (black) and after (blue) adding ML277. Data points were fitted with a Boltzmann function.Figure 7—figure supplement 1. Model simulations of all-state occupancy before and after adding ML277.(A) Model simulations of KCNQ1 all-state occupancy before (black) and after (blue) adding ML277. The voltage protocol was from −120 mV to +40 mV in increment of 10 mV from the −80 mV holding potential, and then stepped to −40 mV. The state occupancies are very similar for RC, IC, AC, and IO states, except for the AO state shows a clear increase after adding ML277. (B) Five-state Markov model. 1/2X K2 and 1/2X β3 can mimic the ML277 effects on KCNQ1 channel.
	Author response image 1. Model simulations of ML277 effects by 2X k1 and 1/2X β3.(A) Model simulations of KCNQ1 activation currents before (black) and after (blue) adding ML277. (B) Five-state Markov model to show the two open states gating processes of KCNQ1 channel. α and β are voltage-dependent transitions. k1-4 are VSD-pore coupling rates (constant). 2X K1 and 1/2X β3 can mimic the ML277 effects on KCNQ1 channel. (C-D) G–V relationships of simulated KCNQ1 before (black) and after (blue) adding ML277. Data points were fitted with a Boltzmann function.
	Author response image 2. Model simulations of deactivation kinetics by ML277.Model simulations of KCNQ1 channel before (black) and after (blue) adding ML277. The activation voltage was +40 mV and then stepped to −120 mV to induce a hook at the tail current. The insets show the tail currents with an expanded time scale. The time course of the deactivation currents was shown as τ. No obvious change of the deactivation kinetics was observed by ML277.
	Author response image 3. Kinetics of the hook current before and after adding ML277.(A) KCNQ1 tail current recorded with a 2.913 s pre-pulse duration (red) was fitted with a double exponential function F(t) = A1×exp(−t/τ1)+ A2×exp(−t/τ2)+ C (Hou et al., 2017). The fitting curve is shown in dotted green line, the deactivation component (A1×exp(−t/τ1)+C) and hook component (A2×exp(−t/τ2)) are shown in green lines. (B) Tail currents in Figure 3A, C were fitted with a double exponential function and time constants of the hook current before (black) and after (blue) adding ML277 were plotted over pre-pulse durations.

Abitbol, Stilbenes and fenamates rescue the loss of I(KS) channel function induced by an LQT5 mutation and other IsK mutants. 1999, Pubmed, Xenbase

Abitbol, Stilbenes and fenamates rescue the loss of I(KS) channel function induced by an LQT5 mutation and other IsK mutants. 1999, Pubmed , Xenbase
Baker, Three transmembrane conformations and sequence-dependent displacement of the S4 domain in shaker K+ channel gating. 1998, Pubmed
Barhanin, K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. 1996, Pubmed , Xenbase
Barro-Soria, KCNE3 acts by promoting voltage sensor activation in KCNQ1. 2015, Pubmed , Xenbase
Barro-Soria, KCNE1 divides the voltage sensor movement in KCNQ1/KCNE1 channels into two steps. 2014, Pubmed
Bezanilla, Gating of Shaker K+ channels: II. The components of gating currents and a model of channel activation. 1994, Pubmed , Xenbase
Boulet, Role of the S6 C-terminus in KCNQ1 channel gating. 2007, Pubmed
Busch, The role of the IsK protein in the specific pharmacological properties of the IKs channel complex. 1997, Pubmed , Xenbase
Carvalho-de-Souza, Nonsensing residues in S3-S4 linker's C terminus affect the voltage sensor set point in K+ channels. 2018, Pubmed , Xenbase
Chan, Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1. 2012, Pubmed
Chiamvimonvat, Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics. 2017, Pubmed
Cruickshank, The Cl(-) channel blocker niflumic acid releases Ca(2+) from an intracellular store in rat pulmonary artery smooth muscle cells. 2003, Pubmed
Cui, Voltage-Dependent Gating: Novel Insights from KCNQ1 Channels. 2016, Pubmed
De Silva, Deconstruction of an African folk medicine uncovers a novel molecular strategy for therapeutic potassium channel activation. 2018, Pubmed , Xenbase
Delemotte, Intermediate states of the Kv1.2 voltage sensor from atomistic molecular dynamics simulations. 2011, Pubmed
Gao, Intracellular zinc activates KCNQ channels by reducing their dependence on phosphatidylinositol 4,5-bisphosphate. 2017, Pubmed
Gao, Desensitization of chemical activation by auxiliary subunits: convergence of molecular determinants critical for augmenting KCNQ1 potassium channels. 2008, Pubmed
Gibor, An inactivation gate in the selectivity filter of KCNQ1 potassium channels. 2007, Pubmed , Xenbase
Glauner, Spectroscopic mapping of voltage sensor movement in the Shaker potassium channel. 1999, Pubmed , Xenbase
Guo, Ginsenoside Rb1, a novel activator of the TMEM16A chloride channel, augments the contraction of guinea pig ileum. 2017, Pubmed
Hill, DIDS modifies the conductance, gating, and inactivation mechanisms of the cardiac ryanodine receptor. 2002, Pubmed
Hoosien, Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome. 2013, Pubmed , Xenbase
Hou, Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening. 2017, Pubmed , Xenbase
Hou, Physiological role of Kv1.3 channel in T lymphocyte cell investigated quantitatively by kinetic modeling. 2014, Pubmed
Jensen, Mechanism of voltage gating in potassium channels. 2012, Pubmed
Keating, Molecular and cellular mechanisms of cardiac arrhythmias. 2001, Pubmed
Lacroix, Intermediate state trapping of a voltage sensor. 2012, Pubmed , Xenbase
Larsen, Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state. 2011, Pubmed , Xenbase
Larsson, Transmembrane movement of the shaker K+ channel S4. 1996, Pubmed , Xenbase
Ledwell, Mutations in the S4 region isolate the final voltage-dependent cooperative step in potassium channel activation. 1999, Pubmed , Xenbase
Liu, Human β-defensin 2 is a novel opener of Ca2+-activated potassium channels and induces vasodilation and hypotension in monkeys. 2013, Pubmed
Ma, Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes. 2015, Pubmed
Mattmann, Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator. 2012, Pubmed
Mruk, Discovery of a novel activator of KCNQ1-KCNE1 K channel complexes. 2009, Pubmed , Xenbase
Murray, Unnatural amino acid photo-crosslinking of the IKs channel complex demonstrates a KCNE1:KCNQ1 stoichiometry of up to 4:4. 2016, Pubmed
Nakagawa, Mexiletine Block of Voltage-Gated Sodium Channels: Isoform- and State-Dependent Drug-Pore Interactions. 2019, Pubmed
Nakajo, Stoichiometry of the KCNQ1 - KCNE1 ion channel complex. 2010, Pubmed , Xenbase
Osteen, KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gate. 2010, Pubmed , Xenbase
Osteen, Allosteric gating mechanism underlies the flexible gating of KCNQ1 potassium channels. 2012, Pubmed , Xenbase
Peng, Gating mechanisms underlying deactivation slowing by two KCNQ1 atrial fibrillation mutations. 2017, Pubmed , Xenbase
Pusch, Activation and inactivation of homomeric KvLQT1 potassium channels. 1998, Pubmed , Xenbase
Pusch, Gating and flickery block differentially affected by rubidium in homomeric KCNQ1 and heteromeric KCNQ1/KCNE1 potassium channels. 2000, Pubmed , Xenbase
Ramasubramanian, The Structural Basis of IKs Ion-Channel Activation: Mechanistic Insights from Molecular Simulations. 2018, Pubmed
Restier, Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels. 2008, Pubmed , Xenbase
Salata, A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents. 1998, Pubmed , Xenbase
Sanguinetti, Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. 1996, Pubmed , Xenbase
Schwartz, Long-QT syndrome: from genetics to management. 2012, Pubmed
Seebohm, Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels. 2003, Pubmed , Xenbase
Seebohm, Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels. 2003, Pubmed , Xenbase
Sigg, Gating current noise produced by elementary transitions in Shaker potassium channels. 1994, Pubmed , Xenbase
Sigworth, Voltage gating of ion channels. 1994, Pubmed
Silva, A multiscale model linking ion-channel molecular dynamics and electrostatics to the cardiac action potential. 2009, Pubmed
Silverman, Structural basis of two-stage voltage-dependent activation in K+ channels. 2003, Pubmed , Xenbase
Strutz-Seebohm, Structural basis of slow activation gating in the cardiac I Ks channel complex. 2011, Pubmed , Xenbase
Sun, Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome. 2017, Pubmed , Xenbase
Tristani-Firouzi, Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits. 1998, Pubmed , Xenbase
Wang, Native gating behavior of ion channels in neurons with null-deviation modeling. 2013, Pubmed
Wang, Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. 1996, Pubmed
Westhoff, IKs ion-channel pore conductance can result from individual voltage sensor movements. 2019, Pubmed
Wu, State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activation. 2010, Pubmed , Xenbase
Wu, KCNE1 remodels the voltage sensor of Kv7.1 to modulate channel function. 2010, Pubmed , Xenbase
Xiong, Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants. 2007, Pubmed
Xu, Probing binding sites and mechanisms of action of an I(Ks) activator by computations and experiments. 2015, Pubmed
Xu, Effects of β-subunit on gating of a potassium ion channel: Molecular simulations of cardiac IKs activation. 2018, Pubmed
Xu, Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin. 2019, Pubmed
Yarotskyy, Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation. 2010, Pubmed
Yazawa, Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. 2011, Pubmed
Yu, Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels. 2013, Pubmed
Yu, Identification of a novel, small molecule activator of KCNQ1 channels 2010, Pubmed
Zagotta, Shaker potassium channel gating. III: Evaluation of kinetic models for activation. 1994, Pubmed , Xenbase
Zaydman, Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening. 2013, Pubmed , Xenbase
Zaydman, Domain-domain interactions determine the gating, permeation, pharmacology, and subunit modulation of the IKs ion channel. 2014, Pubmed , Xenbase
Zhang, Hidden Markov Modeling with Detailed Balance and Its Application to Single Protein Folding. 2016, Pubmed
Zheng, Hexachlorophene is a potent KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutants. 2012, Pubmed
Zhu, Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation. 2019, Pubmed , Xenbase